HIKESHI

protein-coding

heat shock protein nuclear import factor hikeshi

Gene summary

This gene encodes an evolutionarily conserved nuclear transport receptor that mediates heat-shock-induced nuclear import of 70 kDa heat-shock proteins (Hsp70s) through interactions with FG-nucleoporins. The protein mediates transport of the ATP form but not the ADP form of Hsp70 proteins under conditions of heat shock stress. Structural analyses demonstrate that the protein forms an asymmetric homodimer and that the N-terminal domain consists of a jelly-roll/beta-sandwich fold structure that contains hydrophobic pockets involved in FG-nucleoporin recognition. Reduction of RNA expression levels in HeLa cells using small interfering RNAs results in inhibition of heat shock-induced nuclear accumulation of Hsp70s, indicating a role for this gene in regulation of Hsp70 nuclear import during heat shock stress. [provided by RefSeq, Apr 2016]

Previous symbols:
  • C11orf73

MANE transcript

NM_016401.4

Inheritance

AR

ClinVar variants

P:6U:18B:20

Top phenotype

Leukodystrophy, hypomyelinating, 13

gnomAD constraint

pLI —, LoF o/e 0.19

Max pathogenic AF

—

Genomic locus

chr11:86,302,211-86,345,943

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~43.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

leukodystrophy, hypomyelinating, 13DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014813

Submitter: ClinGen

HIKESHI was first reported in relation to autosomal recessive hypomyelinating leukodystrophy-13 (OMIM: 616881) in 2016 (Edvardson et al., PMID: 26545878). Hikeshi protein function is essential to cell viability in conditions of heat stress and mediates the heat stress-induced nuclear import of heat shock protein (Hsp70) through a nuclear pore complex (Helman et al 2021, PMID: 34111619). This disease is clinically characterized by early onset global developmental delay, hypotonia evolving to dystonia or spastic quadriplegia, intellectual disability, and additional variable findings including neurodevelopmental regression, failure to thrive, ocular/visual abnormalities, and microcephaly (PMID: 34111619). Neuroimaging shows diffuse hypomyelination and thin corpus callosum (PMID: 34111619). Three unique missense variants that have been reported in the homozygous state in twelve probands across five publications are included in this curation (PMIDs: 26545878, 28000699, 31912665, 34111619, 38922739). All three missense variants have supporting functional data. Of note, one variant (c.160C>G (p.Val54Leu)) was observed in 10 probands of Ashkenazi Jewish descent and is likely a founder variant in this population. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by an animal model. HIKESHI conditional knockout mice displayed a reduced number of myelinated axons when compared to wildtype mice, as well as decreased thickness of the myelin (PMID: 37865085). These characteristics resemble the human phenotype of hypomyelination. In summary, there is definitive evidence supporting the relationship between HIKESHI and autosomal recessive hypomyelinating leukodystrophy-13 (MONDO:0014813), also known as HIKESHI-related hypomyelinating leukodystrophy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.. This classification was approved by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date October 9, 2024 (SOP Version 11).

c11orf73-related autosomal recessive hypomyelinating leukodystrophyMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0044642

Submitter: Illumina

leukodystrophy, hypomyelinating, 13STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014813

Submitter: PanelApp Australia

leukodystrophy, hypomyelinating, 13STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014813

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Leukodystrophy, hypomyelinating, 13AR

Manifestation: Cardiovascular; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 26545878Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to HIKESHI variants in ClinVar

5 Conditions Cataloged
not providedTotal: 55
not specifiedTotal: 8
Leukodystrophy, hypomyelinating, 13Total: 5
Inborn genetic diseasesTotal: 5
HIKESHI-related disorderTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_016401.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
17
clinvar
2
clinvar
19
missense
3
clinvar
17
clinvar
1
clinvar
21
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total061818244

Highest pathogenic variant AF is 0.0000892378

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 58 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_016401.4RefSeqNP_057485.25MANE Select
ENST00000278483.8EnsemblENSP00000278483.35MANE Select
NM_001322404.2RefSeqNP_001309333.15Standard
NM_001322407.2RefSeqNP_001309336.14Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Regulation of HSF1-mediated heat shock response
  • Cellular responses to stress
  • Cellular responses to external stimuli
  • Cellular response to heat stress

Biological Process

  • protein import into nucleus
  • Golgi organization
  • protein transport
  • lung development
  • cellular response to heat

Molecular Function

  • protein transporter activity
  • Hsp70 protein binding

Cellular Component

  • nucleus
  • nucleoplasm
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000278483
Coding exons
5
Length
43717
Individuals with no LoFs
125725
Homozygous LoFs
0
Heterozygous LoFs
12
Defined
125737
p
0.0000477
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.933751010.7390.000004621286
Missense (PolyPhen)2432.7060.7338439
Synonymous0.4253235.20.9090.00000167377
Loss of Function2.46210.70.1885.38e-7122

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American0.0000580.000058rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.0000930.000092rare
European (Non-Finnish)0.0000710.000070rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Acts as a specific nuclear import carrier for HSP70 proteins following heat-shock stress: acts by mediating the nucleoporin-dependent translocation of ATP-bound HSP70 proteins into the nucleus. HSP70 proteins import is required to protect cells from heat shock damages. Does not translocate ADP-bound HSP70 proteins into the nucleus. {ECO:0000269|PubMed:22541429}.;
Disease
DISEASE: Leukodystrophy, hypomyelinating, 13 (HLD13) [MIM:616881]: An autosomal recessive neurodegenerative disorder with infantile onset, affecting mainly the central white matter. Clinical features include early feeding difficulties, global developmental delay, postnatal progressive microcephaly, truncal hypotonia, spasticity, and variable neurologic deficits, such as visual impairment. {ECO:0000269|PubMed:26545878}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.113

Intolerance Scores

RVIS EVS
0.04
RVIS percentile EVS
56.64

Essentials

Essential (gene trap)
N
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.